The LDL receptor related protein type 6 (LRP6) deficiency: implications for the pathogenesis of type 2 diabetes, arterial hypertension and atherosclerosis
Aguilar-Salinas, C.A.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 98-102
2007
ISSN/ISBN: 0034-8376 PMID: 17633795 Document Number: 608907
Document emailed within 1 workday
Related Documents
Almind, K. 2002: Genetic defects in insulin signalling proteins. Implications for the pathogenesis of type 2 diabetes Ugeskrift for Laeger 164(8): 1021-1026Miyata, T.; Zheng, Y.Z.; Sakata, T.; Tsushima, N.; Kato, H. 1994: Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency Thrombosis and Haemostasis 71(1): 32-37
Kahn, J.P.; Perumal, A.S.; Gully, R.J.; Smith, T.M.; Cooper, T.B.; Klein, D.F. 1987: Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis Lancet 2(8565): 937-939
Pinkhasov, B.B.; Seliatitskaia, V.G.; Mitrofanov, I.M.; Anufrienko, A.V.; Dolgova, N.A. 2014: Combination of arterial hypertension and type 2 diabetes mellitus with obesity Klinicheskaia Meditsina 92(9): 65-69
Barbagallo, M.; Resnick, L.M.; Novo, S.; Putignano, E.; Licata, G. 1993: Role of glucose in determining arterial hypertension in type 2 diabetes mellitus: ion hypothesis Cardiologia 38(11): 743-748
Boero, R.; Prodi, E.; Borsa, S.; Berti, V.; Fiorio, E.; Ferraro, L.; Massara, C.; Quarello, F. 2002: Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(4): 413-418
Karpov, R.S.; Koshel'skaia, O.A.; Soldatenko, M.V.; Efimova, E.V.; Ocheredko, N.A.; Panafidin, A.V. 2004: Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension Klinicheskaia Meditsina 82(6): 17-22
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
Sato, N.; Kase, H.; Kato, T.; Kasai, K. 2003: Effect of angiotensin Ii type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1245-1249
Moleda, P.; Majkowska, L.; Safranow, K.; Goracy, I.; Adler, G. 2007: I/D polymorphism of angiotensin i converting enzyme gene and arterial hypertension in patients with type 2 diabetes mellitus Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 22(129): 169-172
Zvereva, T.N.; Cherniavskaia, E.I.; Barbarash, O.L. 2013: Effect of perindopril on the processes of subclinical inflammation in patients with arterial hypertension and type 2 diabetes mellitus Kardiologiia 53(4): 19-24
Tkacheva, O.N.; Barabashkina, A.V.; Novikova, I.M.; Runikhina, N.K. 2009: The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus Kardiologiia 49(5): 40-47
Li, L.-D.; Tian, M.; Liao, Y.-H.; Zhou, Z.-H.; Wei, F.; Zhu, F.; Wang, M.; Wang, B.; Wei, Y.-M. 2014: Effect of active immunization against angiotensin Ii type 1 (AT1) receptor on hypertension and arterial remodelling in spontaneously hypertensive rats (SHR) Indian Journal of Medical Research 139(4): 619-624
Xiu, L.-l.; Weng, J.-p.; Sui, Y.; Wang, J.; Yan, J.-h.; Huang, Z.-m. 2004: Common variants in beta 3-adrenergic-receptor and uncoupling protein-2 genes are associated with type 2 diabetes and obesity Zhonghua Yi Xue Za Zhi 84(5): 375-379
Shapiro, I.A.; Kalinina, A.M.; Eganian, R.A.; Petrichko, T.A.; P'iankova, E.Iu. 2003: The training programs for correction of the nutritional disturbances behavior in patients with arterial hypertension and diabetes mellitus type 2 Voprosy Pitaniia 72(4): 29-32
Karpov, R.S.; Koshel'skaia, O.A. 2007: Left ventricular remodeling in association of arterial hypertension with diabetes mellitus type 2: correlation with gender and disease duration Terapevticheskii Arkhiv 79(1): 32-38
Mahley, R.W. 1996: Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease Israel Journal of Medical Sciences 32(6): 414-429
McKean, D.J.; Podzorski, R.P.; Bell, M.P.; Nilson, A.E.; Huntoon, C.J.; Slack, J.; Dower, S.K.; Sims, J. 1993: Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity Journal of Immunology 151(7): 3500-3510
Paquot, N.; Tappy, L. 2005: Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis Revue Medicale de Liege 60(5-6): 369-373
Titov, V.N. 2008: Concomitant impairments of essential fatty acids and endothelium-dependent vasodilation in the pathogenesis of arterial hypertension and atherosclerosis Klinicheskaia Laboratornaia Diagnostika 10: 3-14